Literature DB >> 26054992

Topical Agents and Dressings for Pilonidal Sinus Wound Healing by Secondary Intention: A Scoping Review.

Kevin Y Woo1, Enid Wai-Yung Kwong2, Carolina Jimenez3, Richard Bishop4.   

Abstract

Pilonidal disease (PD) is a chronic and debilitating condition. The overall aim of the scoping review is to map and summarize a wide range of evidence to examine which topical agent or dressing is effective in promoting pilonidal wound healing by secondary intention. Review of this cumulative body of evidence will inform care and guide dressing selection for PD related wounds and delineate future research priorities based on identified knowledge gaps and clinical practice issues. Overall, there is some evidence to suggest that topical applications of hydrogel, silver, honey, zinc, selected foam materials, negative pressure wound therapy, platelet rich plasma, and plant extracts may promote wound healing. Topical treatment using polyhexamethylene biguanide and silver may be beneficial in reducing bacterial burden. Finally, silver, honey, and hydrocolloid dressings may help alleviate wound related pain. However, evidence remains insufficient in light of methodological limitations and biases of the studies.

Entities:  

Mesh:

Substances:

Year:  2015        PMID: 26054992

Source DB:  PubMed          Journal:  Surg Technol Int        ISSN: 1090-3941


  2 in total

1.  Injection of freshly collected autologous adipose tissue in complicated pilonidal disease: a prospective pilot study.

Authors:  Vestergaard G Sophie; Sørensen J Marlene; Hougaard T Helene; Lundby Lilli; Pedersen G Allan; Haas Susanne
Journal:  Tech Coloproctol       Date:  2022-08-13       Impact factor: 3.699

2.  Does application of honey improve surgical outcome in pilonidal cyst excision with secondary intention healing? A prospective randomized placebo-controlled clinical trial.

Authors:  Vahid Salehi; Mohammad Javad Yavari Barhaghtalab; Saadat Mehrabi; Aida Iraji; Seyed Alimohammad Sadat; Seyed Hadi Yusefi; Jan Mohamad Malekzadeh
Journal:  Perioper Med (Lond)       Date:  2022-01-10
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.